Alexandra E Gould

USPTO Granted Patents = 12 (Patent Applications = 9)

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 4.0

ph-index = 4

Forward Citations = 137(Granted Patents)

Company Filing History:

10 out of 850

Millennium Pharmaceuticals Limited

patents

2 out of 1,179

Takeda Pharmaceutical Company Limited

patents

Years Active: 2003-2024

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12054512 - Sting modulator compounds, and methods of making and using (2024-08-06),

2. 11542293 - Sting modulator compounds, and methods of making and using (2023-01-03),

3. 10865208 - ATG7 inhibitors and the uses thereof (2020-12-15),

4. 9593121 - Indole substituted pyrrolopyrimidinyl inhibitors of Uba6 (2017-03-14),

5. 8778931 - Substituted hydroxamic acids and uses thereof (2014-07-15),

6. 8765773 - Substituted hydroxamic acids and uses thereof (2014-07-01),

7. 8513421 - Substituted hydroxamic acids and uses thereof (2013-08-20),

8. 8110687 - Bicyclic compounds with kinase inhibitory activity (2012-02-07),

9. 7795249 - Certain pyrazoline derivatives with kinase inhibitory activity (2010-09-14),

10. 7652041 - Cinnamide and hydrocinnamide derivatives with kinase inhibitory activity (2010-01-26),

11. 7045532 - ACE-2 modulating compounds and methods of use thereof (2006-05-16),

12. 6632830 - ACE-2 inhibiting compounds and methods of use thereof (2003-10-14),

Title: Innovator Spotlight: Alexandra E. Gould and Her Contributions to Cancer Research

Introduction: Alexandra E. Gould, based in Cambridge, MA, is an accomplished inventor with a remarkable portfolio of 12 patents. Her innovative work primarily focuses on STING (Stimulator of Interferon Genes) modulators and their potential applications in cancer treatment and related diseases. Through her dedication to scientific advancement, she has made significant contributions to the field of biomedicine.

Latest Patents: Among her latest patents, Alexandra has developed novel STING modulator compounds which provide methods of synthesis and use for the prophylaxis or treatment of cancer and other STING-related diseases. The disclosed compounds are represented by a specific formula, with the potential to transform therapeutic approaches to combating cancer. These developments highlight her commitment to advancing healthcare and improving patient outcomes through innovative research.

Career Highlights: Alexandra's career includes significant tenures at renowned organizations. She has contributed her expertise to Millennium Pharmaceuticals Limited and Takeda Pharmaceutical Company Limited, where she played pivotal roles in research and development. Her work has not only expanded the boundaries of cancer treatment but has also paved the way for future investigational therapies.

Collaborations: Throughout her career, Alexandra E. Gould has collaborated with esteemed colleagues in her field, including Paul D. Greenspan and Dylan Bradley England. These partnerships have fostered a productive environment for innovation, leading to breakthroughs in drug development and treatment methodologies.

Conclusion: Alexandra E. Gould stands out as a formidable inventor in the realm of biomedicine, particularly in the context of cancer research and treatment. With her numerous patents and collaborations, she continues to push the frontiers of medical innovation, bringing hope to countless individuals affected by cancer and related diseases. Her contributions exemplify the significant impact that dedicated inventors can have on research and healthcare.

This text is generated by artificial intelligence and may not be accurate.